Health Care: Drugs

ACADIA Pharmaceuticals Inc (ACAD: NASDAQ)

$37.97 n/a | n/a%
02/27/15 - 04:00 PM ET
Company Income Statement
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Sales 120.00K 1.14M 4.91M 2.07M
Cost of Sales 0.00 0.00 0.00 0.00
Gross Operating Profit 120.00K 1.14M 4.91M 2.07M
Selling, General, and Administrative Expenses 32.75M 12.72M 7.00M 7.61M
Research & Development 60.60M 26.72M 18.79M 17.31M
Operating Income before D & A (EBITDA) -93.23M -38.30M -20.89M -22.85M
Depreciation & Amortization n.a. 1.61M -24.00K 390.00K
Interest Income 755.00K 349.00K 37.00K 87.00K
Other Income - Net 0.00 0.00 0.00 0.00
Special Income / Charges n.a. 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -92.48M -39.56M -20.82M -23.16M
Interest Expense 0.00 0.00 0.00 0.00
Pre-Tax Income -92.48M -39.56M -20.82M -23.16M
Income Taxes 0.00 0.00 0.00 0.00
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -92.48M -37.95M -20.85M -22.76M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -92.48M -37.95M -20.85M -22.76M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -92.48M -37.95M -20.85M -22.76M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
n.a. -37.95M -20.85M -22.76M
Preferred Dividends
Net Income Available To Common 0.00 -37.95M -20.85M -22.76M
Basic EPS from Continuing Ops. -0.95 -0.44 -0.38 -0.44
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -0.95 -0.44 -0.38 -0.44
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -0.95 -0.44 -0.38 -0.44
Basic Normalized Net Income/Share n.a. -0.44 -0.38 -0.44
EPS fr Continuing Ops. -0.95 -0.44 -0.38 -0.44
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -0.95 -0.44 -0.38 -0.44
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -0.95 -0.44 -0.38 -0.44
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
n.a. -0.44 -0.38 -0.44
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with ACAD

Latest ACAD Headlines from TheStreet

More Financial News for ACAD

Press Releases for ACAD

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter